{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:08:44Z","timestamp":1783703324070,"version":"3.55.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11908-017-0592-7","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T08:59:14Z","timestamp":1503392354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Opportunistic Invasive Mycoses in AIDS: Cryptococcosis, Histoplasmosis, Coccidiodomycosis, and Talaromycosis"],"prefix":"10.1007","volume":"19","author":[{"given":"Daniel B.","family":"Chastain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s F.","family":"Henao-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Franco-Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"issue":"7","key":"592_CR1","first-page":"375","volume":"11","author":"NE Haddad","year":"2001","unstructured":"Haddad NE, Powderly WG. The changing face of mycoses in patients with HIV\/AIDS. AIDS Read. 2001;11(7):375\u20138.","journal-title":"AIDS Read"},{"issue":"1","key":"592_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12066","volume":"254","author":"AA Sm Okoye","year":"2013","unstructured":"Sm Okoye AA, Picker LJ. CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev. 2013 Jul;254(1):54\u201364. doi:10.1111\/imr.12066.","journal-title":"Immunol Rev"},{"issue":"6","key":"592_CR3","doi-asserted-by":"publisher","first-page":"8862","DOI":"10.1093\/infdis\/jiw085","volume":"214","author":"K Buchacz","year":"2016","unstructured":"Buchacz K, Lau B, Jing Y, Bosch R, Abraham AG, Gill MJ, et al. Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000\u20132010. J Infect Dis. 2016;214(6):8862\u201372.","journal-title":"J Infect Dis"},{"key":"592_CR4","doi-asserted-by":"publisher","first-page":"165rv113","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"GD Brown","year":"2012","unstructured":"Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4:165rv113.","journal-title":"Sci Transl Med"},{"key":"592_CR5","first-page":"116","volume":"23","author":"H Masur","year":"2015","unstructured":"Masur H. HIV related opportunistic infections are still relevant in 2015. Top Antivir Med. 2015;23:116\u20139.","journal-title":"Top Antivir Med"},{"key":"592_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1126\/science.1222236","volume":"336","author":"GD Brown","year":"2012","unstructured":"Brown GD, Denning DW, Levitz SM. Tackling human fungal infections. Science. 2012;336:647.","journal-title":"Science"},{"issue":"11","key":"592_CR7","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2165\/00003495-200464110-00002","volume":"64","author":"M Ruhnke","year":"2004","unstructured":"Ruhnke M. Mucosal and systemic fungal infections in patients with AIDS: prophylaxis and treatment. Drugs. 2004;64(11):1163\u201380.","journal-title":"Drugs"},{"issue":"4","key":"592_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.semdp.2017.05.003","volume":"34","author":"J Guarner","year":"2017","unstructured":"\u2022\u2022 Guarner J. Human immunodeficiency virus and fungal infections. Semin Diagn Pathol. 2017;34(4):313. doi:10.1053\/j.semdp.2017.05.003. This article provides an excellent overview on the diagnosis of AIDS-related fungal mycoses.","journal-title":"Semin Diagn Pathol"},{"issue":"11","key":"592_CR9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrneurol.2016.149","volume":"12","author":"LN Bowen","year":"2016","unstructured":"Bowen LN, Smith B, Reich D, Quezado M, Nath A. HIV-associated opportunistic CNS infections: pathophysiology, diagnosis, and treatment. Nat Rev Neurol. 2016;12(11):662\u201374.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"592_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.tim.2017.02.013","volume":"25","author":"D Armstrong-James","year":"2017","unstructured":"\u2022 Armstrong-James D, Bicanic T, Brown GD, Hoving JC, Meintjes G, Nielsen K, et al. AIDS-related mycoses: current progress in the field and future priorities. Trends Microbiol. 2017;25(6):428\u201330. This article provides a summary of advances in research in addressing AIDS-related mycoses and next steps needed to close the gap.","journal-title":"Trends Microbiol"},{"key":"592_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.tim.2014.01.001","volume":"22","author":"D Armstrong-James","year":"2014","unstructured":"\u2022\u2022 Armstrong-James D, Meintjes G, Brown GD. A neglected epidemic: fungal infections in HIV\/AIDS. Trends Microbiol. 2014;22:120\u20137. This article summarizes the epidemiology, clinical aspects, and treatment of the major AIDS-related mycoses.","journal-title":"Trends Microbiol"},{"issue":"3","key":"592_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1128\/CMR.00001-12","volume":"25","author":"TR O\u2019Meara","year":"2012","unstructured":"O\u2019Meara TR, Alspaugh JA. The Cryptococcus neoformans capsule: a sword and a shield. Clin Microbiol Rev. 2012;25(3):387\u2013408. doi:10.1128\/CMR.00001-12.","journal-title":"Clin Microbiol Rev"},{"key":"592_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.fgb.2014.10.003","volume":"78","author":"JR Perfect","year":"2015","unstructured":"Perfect JR, Bicanic T. Cryptococcosis diagnosis and treatment: what do we know now. Fungal Genet Biol. 2015;78:49\u201354. doi:10.1016\/j.fgb.2014.10.003.","journal-title":"Fungal Genet Biol"},{"issue":"5","key":"592_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/mmy.38.5.379.383","volume":"38","author":"MS Lazera","year":"2000","unstructured":"Lazera MS, Salmito Cavalcanti MA, Londero AT, Trilles L, Nishikawa MM, Wanke B. Possible primary ecological niche of Cryptococcus neoformans. Med Mycol. 2000;38(5):379\u201383.","journal-title":"Med Mycol"},{"issue":"3","key":"592_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S1473-3099(14)70945-4","volume":"15","author":"C Franco-Paredes","year":"2014","unstructured":"Franco-Paredes C, Sellers B, Hayes A, Chane T, Patel K, Marr K. Management of Cryptococcus gattii meningoencephalitis. Lancet Infect Dis. 2014;15(3):348\u201355. doi:10.1016\/S1473-3099(14)70945-4.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"592_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","volume":"23","author":"BJ Park","year":"2009","unstructured":"Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS. AIDS. 2009;23(4):525\u201330.","journal-title":"AIDS"},{"key":"592_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","volume":"16","author":"N French","year":"2002","unstructured":"French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS. 2002;16:1031\u20138.","journal-title":"AIDS"},{"issue":"2","key":"592_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12281-016-0256-3","volume":"10","author":"E Nalintya","year":"2016","unstructured":"Nalintya E, Kiggundu R, Meya D. Evolution of cryptococcal antigen testing: what is new? Curr Fungal Infect Rep. 2016;10(2):62\u20137.","journal-title":"Curr Fungal Infect Rep"},{"issue":"7","key":"592_CR19","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/jcm.32.7.1680-1684.1994","volume":"32","author":"DC Tanner","year":"1994","unstructured":"Tanner DC, Weinstein MP, Fedorciw B, Joho KL, Thorpe JJ, Reller L. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol. 1994;32(7):1680\u20134.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"592_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/cid\/cir613","volume":"53","author":"JN Jarvis","year":"2011","unstructured":"Jarvis JN, Percival A, Bauman S, Pelfrey J, Meintjes G, Williams GN, et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis. 2011;53(10):1019\u201323.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"592_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3201\/eid2001.130906","volume":"20","author":"DR Boulware","year":"2014","unstructured":"Boulware DR, Rolfes MA, Rajasingham R, von Hohenberg M, Qin Z, Taseera K, et al. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. Emerg Infect Dis. 2014;20(1):45\u201353.","journal-title":"Emerg Infect Dis"},{"key":"592_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/cid\/civ263","volume":"61","author":"DA Williams","year":"2015","unstructured":"Williams DA, Kiiza T, Kwizera R, et al. Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study. Clin Infect Dis. 2015;61:464\u20137.","journal-title":"Clin Infect Dis"},{"key":"592_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40475-015-0045-z","volume":"2","author":"D Meya","year":"2015","unstructured":"Meya D, Rajasingham R, Nalintya E, et al. Preventing cryptococcosis\u2014shifting the paradigm in the era of highly active antiretroviral therapy. Curr Trop Med Rep. 2015;2:81\u20139.","journal-title":"Curr Trop Med Rep"},{"issue":"12","key":"592_CR24","doi-asserted-by":"publisher","first-page":"e51291","DOI":"10.1371\/journal.pone.0051291","volume":"7","author":"EK Butler","year":"2012","unstructured":"Butler EK, Boulware DR, Bohjanen PR, Meya DB. Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda. PLoS One. 2012;7(12):e51291.","journal-title":"PLoS One"},{"issue":"9983","key":"592_CR25","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","volume":"385","author":"S Mfinanga","year":"2015","unstructured":"Mfinanga S, Chanda D, Kivuyo SL, Guinness L, Bottomley C, REMSTART trial team, et al. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial. Lancet. 2015;385(9983):2173\u201382.","journal-title":"Lancet"},{"key":"592_CR26","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Available at http:\/\/apps.who.int\/iris\/bitstream\/10665\/186275\/1\/9789241509565_eng.pdf?ua=1. Accessed April 28, 2017."},{"key":"592_CR27","unstructured":"DHHS Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf. Accessed April 28, 2017."},{"key":"592_CR28","first-page":"383","volume":"96","author":"S Farmer","year":"1973","unstructured":"Farmer S, Komorowski R. Histologic response to capsule-deficient Cryptococcus neoformans. Arch Pathol. 1973;96:383\u20137.","journal-title":"Arch Pathol"},{"key":"592_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nmni.2014.12.003","volume":"4","author":"O Opota","year":"2014","unstructured":"Opota O, Desgraz B, Kenfak A, et al. Cryptococcus neoformans meningitis with negative cryptococcal antigen: evaluation of a new immunochromatographic detection assay. New Microbes New Infect. 2014;4:1\u20134.","journal-title":"New Microbes New Infect"},{"issue":"6","key":"592_CR30","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1128\/jcm.33.6.1674-1675.1995","volume":"33","author":"LB Blevins","year":"1995","unstructured":"Blevins LB, Fenn J, Segal H, Newcomb-Gayman P, Carroll KC. False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps. J Clin Microbiol. 1995;33(6):1674\u20135.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"592_CR31","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1128\/JCM.01169-10","volume":"49","author":"DA Wilson","year":"2011","unstructured":"Wilson DA, Sholtis M, Parshall S, Hall GS, Procop GW. False-positive cryptococcal antigen test associated with use of BBL Port-a-cul transport vials. J Clin Microbiol. 2011;49(2):702\u20133.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"592_CR32","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1128\/AAC.01800-12","volume":"57","author":"EW Bratton","year":"2013","unstructured":"Bratton EW, El Husseini N, Chastain CA, Lee MS, Poole C, St\u00fcrmer T, et al. Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis. Antimicrob Agents Chemother. 2013;57(6):2485\u201395.","journal-title":"Antimicrob Agents Chemother"},{"key":"592_CR33","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","volume":"368","author":"JN Day","year":"2013","unstructured":"Day JN, Chau TTH, Wolbers M, et al. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med. 2013;368:1291\u2013302.","journal-title":"N Engl J Med"},{"issue":"6","key":"592_CR34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1056\/NEJMoa1509024","volume":"374","author":"J Beardsley","year":"2016","unstructured":"Beardsley J, Wolbers M, Kibengo FM, et al. Adjunctive dexamethasone in HIV-associated cryptococcal meningitis. N Engl J Med. 2016;374(6):542\u201354.","journal-title":"N Engl J Med"},{"issue":"1","key":"592_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12941-017-0184-2","volume":"16","author":"C Franco-Paredes","year":"2017","unstructured":"Franco-Paredes C, Chastain DB, Rodriguez-Morales AJ, Marcos LA. Cryptococcal meningoencephalitis in HIV\/AIDS: when to start antiretroviral therapy? Ann Clin Microbiol Antimicrob. 2017;16(1):9.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"11","key":"592_CR36","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/cid\/ciu596","volume":"59","author":"MA Rolfes","year":"2014","unstructured":"Rolfes MA, Hullsiek KH, Rhein J, Nabeta HW, Taseera K, Schutz C, et al. The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis. Clin Infect Dis. 2014;59(11):1607\u201314.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"592_CR37","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1086\/428618","volume":"40","author":"SA Shelburne 3rd","year":"2005","unstructured":"Shelburne SA 3rd, Darcourt J, White AC Jr, et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40(7):1049\u201352.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"592_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","volume":"10","author":"M Muller","year":"2010","unstructured":"Muller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(4):251\u201361.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"592_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.2016.8900","volume":"316","author":"HF G\u00fcnthard","year":"2016","unstructured":"G\u00fcnthard HF, Saag MS, Benson CA, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the international antiviral society-USA panel. JAMA. 2016;316(2):191\u2013210.","journal-title":"JAMA"},{"issue":"26","key":"592_CR40","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","volume":"370","author":"DR Boulware","year":"2014","unstructured":"Boulware DR, Meya DB, Muzoora C, et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med. 2014;370(26):2487\u201398.","journal-title":"N Engl J Med"},{"issue":"1","key":"592_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1128\/CMR.00027-06","volume":"20","author":"CA Kauffman","year":"2007","unstructured":"Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007;20(1):115\u201332.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"592_CR42","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1086\/513653","volume":"24","author":"DS McKinsey","year":"1997","unstructured":"McKinsey DS, Spiegel RA, Hutwagner L, et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis. 1997;24(6):1195\u2013203.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"592_CR43","first-page":"119","volume":"1","author":"AA Adenis","year":"2014","unstructured":"Adenis AA, Aznar C, Couppie P. Histoplasmosis in HIV-infected patients: a review of new developments and remaining gaps. Curr Trop Med Rep. 2014;1(2):119\u201328.","journal-title":"Curr Trop Med Rep"},{"issue":"2","key":"592_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.diagmicrobio.2008.05.006","volume":"62","author":"JW Baddley","year":"2008","unstructured":"Baddley JW, Sankara IR, Rodriquez JM, Pappas PG, Many WJ Jr. Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy. Diagn Microbiol Infect Dis. 2008;62(2):151\u20136.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"592_CR45","doi-asserted-by":"publisher","first-page":"e2638","DOI":"10.1371\/journal.pntd.0002638","volume":"8","author":"M Nacher","year":"2014","unstructured":"Nacher M, Adenis A, Blanchet D, Vantilcke V, Demar M, Basurko C, et al. Risk factors for disseminated histoplasmosis in a cohort of HIV-infected patients in French Guiana. PLoS Negl Trop Dis. 2014;8(1):e2638.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"592_CR46","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1086\/319756","volume":"32","author":"RA Hajjeh","year":"2001","unstructured":"Hajjeh RA, Pappas PG, Henderson H, Lancaster D, Bamberger DM, Skahan KJ, et al. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis. 2001;32(8):1215\u201320.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"592_CR47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/cid\/cir435","volume":"53","author":"CA Hage","year":"2011","unstructured":"Hage CA, Ribes JA, Wengenack NL, Baddour LM, Assi M, McKinsey DS, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011;53(5):448\u201354.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"592_CR48","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.tim.2003.08.007","volume":"11","author":"LJ Wheat","year":"2003","unstructured":"Wheat LJ. Current diagnosis of histoplasmosis. Trends Microbiol. 2003;11(10):488\u201394.","journal-title":"Trends Microbiol"},{"issue":"7","key":"592_CR49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/521259","volume":"45","author":"LJ Wheat","year":"2007","unstructured":"Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, et al. Infectious Diseases Society of America. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(7):807\u201325.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"592_CR50","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1128\/JCM.03175-14","volume":"53","author":"ES Theel","year":"2015","unstructured":"Theel ES, Harrin JA, Dababneh AS, Rollins LO, Bestrom JE, Jespersen DJ. Reevaluation of commercial reagents for detection of Histoplasma capsulatum antigen in urine. J Clin Microb. 2015;53(4):1198\u2013203.","journal-title":"J Clin Microb"},{"issue":"12","key":"592_CR51","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1177\/106002809302701218","volume":"27","author":"RH Drew","year":"1993","unstructured":"Drew RH. Pharmacotherapy of disseminated histoplasmosis in patients with AIDS. Ann Pharmacother. 1993;27(12):1510\u20138.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"592_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4322\/acr.2016.048","volume":"6","author":"R Kiggundu","year":"2016","unstructured":"Kiggundu R, Nabeta HW, Okia R, Rhein J, Lukande R. Unmasking histoplasmosis immune reconstitution inflammatory syndrome in a patient recently started on antiretroviral therapy. Autops Case Rep. 2016;6(4):27\u201333.","journal-title":"Autops Case Rep"},{"issue":"3","key":"592_CR53","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1128\/CMR.00005-13","volume":"26","author":"C Nguyen","year":"2013","unstructured":"Nguyen C, Barker BM, Hoover S, Nix DE, Ampel NM, Frelinger JA, et al. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis. Clin Microbiol Rev. 2013;26(3):505\u201325.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"592_CR54","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciu681","volume":"60","author":"AP Litvintseva","year":"2015","unstructured":"Litvintseva AP, Marsden-Haug N, Hurst S, Hill H, Gade L, Driebe EM, et al. Valley fever: finding new places for an old disease: Coccidioides immitis found in Washington state soil associated with recent human infection. Clin Infect Dis. 2015;60(1):e1\u20133.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"592_CR55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1128\/JCM.02230-06","volume":"45","author":"MA Saubolle","year":"2007","unstructured":"Saubolle MA, McKellar PP, Sussland D. Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis. J Clin Microbiol. 2007;45(1):26\u201330.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"592_CR56","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1086\/444502","volume":"41","author":"NM Ampel","year":"2005","unstructured":"Ampel NM. Coccidioidomycosis in persons infected with HIV type 1. Clin Infect Dis. 2005;41(8):1174\u20138.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"592_CR57","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/cid\/civ585","volume":"61","author":"C Kassis","year":"2015","unstructured":"Kassis C, Zaidi S, Kuberski T, et al. Role of coccidioides antigen testing in the cerebrospinal fluid for the diagnosis of coccidioidal meningitis. Clin Infect Dis. 2015;61(10):1521\u20136.","journal-title":"Clin Infect Dis"},{"key":"592_CR58","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1128\/CMR.3.3.247","volume":"3","author":"D Pappagianis","year":"1990","unstructured":"Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev. 1990;3:247\u201368.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"592_CR59","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1093\/cid\/ciw360","volume":"63","author":"JN Galgiani","year":"2016","unstructured":"Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63(6):e112\u201346.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"592_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064249","volume":"8","author":"G Thompson 3rd","year":"2013","unstructured":"Thompson G 3rd, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, Taylor S, et al. Routine CSF analysis in coccidioidomycosis is not required. PLoS One. 2013;8(5):e64249.","journal-title":"PLoS One"},{"issue":"3","key":"592_CR61","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/cid\/ciw305","volume":"63","author":"GR Thompson 3rd","year":"2016","unstructured":"Thompson GR 3rd, Rendon A, Ribeiro Dos Santos R, Queiroz-Telles F, Ostrosky-Zeichner L, Azie N, et al. Isavuconazole treatment of cryptococcosis and dimorphic mycoses. Clin Infect Dis. 2016;63(3):356\u201362.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"592_CR62","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/cid\/cir734","volume":"53","author":"R Schein","year":"2011","unstructured":"Schein R, Homans J, Larsen RA, Neely M. Posaconazole for chronic refractory coccidioidal meningitis. Clin Infect Dis. 2011;53(12):1252\u20134.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"592_CR63","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.diagmicrobio.2011.10.002","volume":"72","author":"A D'Avino","year":"2012","unstructured":"D'Avino A, Di Giambenedetto S, Fabbiani M, Farina S. Coccidioidomycosis of cervical lymph nodes in an HIV-infected patient with immunologic reconstitution on potent HAART: a rare observation in a nonendemic area. Diagn Microbiol Infect Dis. 2012;72(2):185\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"592_CR64","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3201\/eid1901.120889","volume":"19","author":"R Trible","year":"2013","unstructured":"Trible R, Edgerton N, Hayek S, Winkel D, Anderson AM. Antiretroviral therapy-associated coccidioidal meningitis. Emerg Infect Dis. 2013;19(1):163\u20135.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"592_CR65","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/cid\/cir028","volume":"52","author":"T Le","year":"2011","unstructured":"Le T, Wolbers M, Chi NH, Quang VM, Chinh NT, Lan NP, et al. Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam. Clin Infect Dis. 2011;52(7):945\u201352.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"592_CR66","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1128\/JCM.42.11.5070-5075.2004","volume":"42","author":"H Gugnani","year":"2004","unstructured":"Gugnani H, Fisher MC, Paliwal-Johsi A, Vanittanakom N, Singh I, Yadav PS. Role of Cannomys badius as a natural animal host of Penicillium marneffei in India. J Clin Microbiol. 2004;42(11):5070\u20135.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"592_CR67","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1086\/338154","volume":"34","author":"S Chariyalertsak","year":"2002","unstructured":"Chariyalertsak S, Supparatpinyo K, Sirisanthana T, Nelson KE. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clin Infect Dis. 2002;34(2):277\u201384.","journal-title":"Clin Infect Dis"},{"key":"592_CR68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11046-012-9577-0","volume":"175","author":"Y Hu","year":"2013","unstructured":"Hu Y, Zhang J, Li X, et al. Penicillium marneffei infection: an emerging disease in mainland China. Mycopathologia. 2013;175:57\u201367.","journal-title":"Mycopathologia"},{"key":"592_CR69","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.medmal.2014.09.008","volume":"44","author":"VT Son","year":"2014","unstructured":"Son VT, Khue PM, Strobel M. Penicilliosis and AIDS in Haiphong, Vietnam: evolution and predictive factors of death. Med Mal Infect. 2014;44:495\u2013501.","journal-title":"Med Mal Infect"},{"issue":"8915","key":"592_CR70","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0140-6736(94)91287-4","volume":"344","author":"K Supparatpinyo","year":"1994","unstructured":"Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet. 1994;344(8915):110\u20133.","journal-title":"Lancet"},{"issue":"4","key":"592_CR71","first-page":"268","volume":"45","author":"KH Ranjana","year":"2002","unstructured":"Ranjana KH, Priyokumar K, Singh TJ, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Inf Secur. 2002;45(4):268\u201371.","journal-title":"J Inf Secur"},{"key":"592_CR72","doi-asserted-by":"publisher","first-page":"e28796","DOI":"10.1371\/journal.pone.0028796","volume":"6","author":"Y-F Wang","year":"2011","unstructured":"Wang Y-F, Cai J-P, Wang Y-D, et al. Immunoassays based on Penicillium marneffei Mp1p derived from Pichia pastoris expression system for diagnosis of penicilliosis. PLoS One. 2011;6:e28796.","journal-title":"PLoS One"},{"key":"592_CR73","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10096-016-2583-2","volume":"35","author":"K Prakit","year":"2016","unstructured":"Prakit K, Nosanchuk JD, Pruksaphon K, et al. A novel inhibition ELISA for the detection and monitoring of Penicillium marneffei antigen in human serum. Eur J Clin Microbiol Infect Dis. 2016;35:647\u201356.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"592_CR74","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.cmi.2014.12.014","volume":"21","author":"Y-F Wang","year":"2015","unstructured":"Wang Y-F, Xu H-F, Han Z-G, et al. Serological surveillance for Penicillium marneffei infection in HIV-infected patients during 2004\u20132011 in Guangzhou, China. Clin Microbiol Infect. 2015;21:484\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"592_CR75","doi-asserted-by":"crossref","unstructured":"Le T, Kinh NV, Cuc NTK, Tung NLN, Lam NT, Thuy PTT, et al. A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis. N Engl J Med. 2017;376(24):2329\u201340.","DOI":"10.1056\/NEJMoa1613306"},{"issue":"5","key":"592_CR76","first-page":"464","volume":"55","author":"W Manosuthi","year":"2007","unstructured":"Manosuthi W, Chaovavanich A, Tansuphaswadikul S, et al. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. J Inf Secur. 2007;55(5):464\u20139.","journal-title":"J Inf Secur"},{"key":"592_CR77","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1742-6405-4-21","volume":"4","author":"S Gupta","year":"2007","unstructured":"Gupta S, Mathur P, Maskey D, Wig N, Singh S. Immune restoration syndrome with disseminated Penicillium marneffei and cytomegalovirus co-infections in an AIDS patient. AIDS Res Ther. 2007;4:21.","journal-title":"AIDS Res Ther"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-017-0592-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-017-0592-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-017-0592-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:40:28Z","timestamp":1659091228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-017-0592-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["592"],"URL":"https:\/\/doi.org\/10.1007\/s11908-017-0592-7","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]},"assertion":[{"value":"22 August 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"36"}}